History matters: Preventing severe allergic transfusion reactions
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqaf093 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Edina A Wappler-Guzzetta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, United States. Hauptthemen laut MEDLINE: Transfusion Reaction, Anti-Allergic Agents, Hypersensitivity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Prior studies have shown that pretransfusion medication is not effective in preventing allergic transfusion reactions (ATRs), but these studies did not consider the patient’s history of ATR. This study evaluated whether pretransfusion antiallergy medications decrease the chance of ATRs in patients with a history of severe ATR.
Methods
This single-center, retrospective study investigated the effect of pretransfusion medications on preventing ATRs in patients with a history of at least 1 severe ATR between March 2018 and January 2024. Patient demographics as well as clinical and transfusion reaction data were collected from our electronic health record (EHR) system. Data were analyzed using SPSS (IBM Corp) and machine learning in Python, version 3.12.4.
Results
In our cohort, 53 patients aged 5 weeks to 94 years with 2767 analyzable transfusion encounters had experienced 88 lifelong mild and severe ATRs. Premedication (P = .021), regular antiallergy medication (P < .001), and washing/volume reduction (P = .032) were associated with a statistically significantly lower chance of developing ATRs in our patient population.
Conclusions
Patients with at least 1 severe ATR benefit from pretransfusion administration of antiallergy medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, United States.
- College of Business and Economics, California State University Fullerton, Fullerton, CA, United States.
- Centennial High School, Corona, CA, United States.
- Department of Pathology and Laboratory Medicine, University of California San Francisco, San Francisco, CA, United States.
Zitieren
APA
Wappler-Guzzetta, E. A., Shafiq, A., Asad, U., Chakravarty, T., & Nedelcu, E. G. (2025). History matters: Preventing severe allergic transfusion reactions. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf093
Vancouver
Wappler-Guzzetta EA, Shafiq A, Asad U, Chakravarty T, Nedelcu EG. History matters: Preventing severe allergic transfusion reactions. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf093
BibTeX
@article{WapplerGuzzetta2025,
author = {Wappler-Guzzetta, Edina A and Shafiq, Asad and Asad, Umaima and Chakravarty, Tushar and Nedelcu, Elena G},
title = {History matters: Preventing severe allergic transfusion reactions},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqaf093}
}
EUVIMED